Full-Time

Global Clinical Development Strategy Expert

Vaccines

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Mid

Waltham, MA, USA + 1 more

More locations: East Side, PA, USA

Position can be based in either Swiftwater, PA or Waltham, MA.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • You will lead the clinical study team and as such requires leadership skills, communications skills, ability to operate in multidisciplinary and multi-cultural teams, ability to inspire teams.
  • Physician, with training in Pediatrics or Internal Medicine in addition to training or experience in immunology or infectious diseases, preferred. MD is a minimum scientific qualification.
  • 3+ years Pharmaceutical industry experience preferred, with exposure to diverse array of programs in early and late-stage development or
  • 3+ years or more experience conducting early and late-stage clinical trials in an academic environment
  • Demonstrated scientific productivity (publications, research reports, etc.) and ability to critically review/interpret research data, preferred.
  • Demonstrated planning, organizational skills, interpersonal, problem solving and excellent written and verbal communication skills.
  • Ability to work independently across many interfaces and platforms in a matrix, cross-cultural environment is essential.
  • Written and oral fluency in English required.
  • M.D. with completion of an approved residency training program in a related field or equivalent is preferred.
Responsibilities
  • Provide scientific and clinical leadership in the design and development of clinical studies and programs for Sanofi Vaccines R&D.
  • Have global responsibility and ownership for the Clinical Strategy, the respective Clinical Development Plans (CDP) and study protocols for projects/programs.
  • Ensure that CDPs are written in accordance with the Target Product Profile (TPP), Integrated Evidence Generation Plan (IEGP) and according to Franchise and Global Project Team strategy and assures global consistency across regions.
  • Provide clinical and R&D expertise, guidance and direction in the context of the region/country, in which they operate.
  • Establishes the conditions essential for determining the safety of all subjects involved in Clinical trials for the vaccine development candidates they oversee.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?